Mckesson Corp

NYSE:MCKUnited States

By David Wainer

Drug middlemen are duking it out to buy their customers.

Most Americans pick up their prescription drugs at the local pharmacy, but many pricey medications are bought directly by medical providers. Think, for example, of a chemotherapy infusion delivered at a doctor's office. The intermediaries selling drugs to those doctors run a pretty good business. Now, the big three U.S. drug wholesalers -- McKesson, Cencora and Cardinal Health -- are taking control of the doctors, too, to lock them in as customers.

McKesson Corporation (MCK) is currently at $477.78, down $2.71 or 0.56%

--Would be lowest close since Jan. 8, 2024, when it closed at $476.63

--Currently down seven consecutive days; down 8.09% over this period